Literature DB >> 9752860

Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment.

A Sasaki1, M Aramaki, K Kawano, Y Morii, K Nakashima, T Yoshida, S Kitano.   

Abstract

BACKGROUND: Classification of macroscopic appearance and standard operative procedures for intrahepatic cholangiocarcinoma (ICC) are still controversial.
METHODS: The mode of spread of 12 resected ICCs was examined by light microscopy, and the appropriate operative procedures for the various tumours were considered.
RESULTS: Macroscopically, nine tumours were classified as mass-forming type and three as periductal infiltrating type. All patients were treated by major hepatectomy; resection of the extrahepatic bile duct was included in two cases of the periductal infiltrating type. Microscopically, invasion into the portal vein, intrahepatic metastasis and perineural or lymphatic vessel invasion occurred in none, one and all of three tumours of the periductal infiltrating type and in eight, six and six of nine tumours of the mass-forming type.
CONCLUSION: ICC of the periductal infiltrating type has a tendency to spread along Glisson's sheath via lymphatic vessels. By contrast, ICC of the mass-forming type tends to invade the liver via the portal vein system; such tumours begin to invade Glisson's sheath through the lymphatic vessels when the tumour has increased in size. Therefore, major hepatectomy with combined resection of the extrahepatic bile duct should be performed for all ICCs of the periductal infiltrating type and for those of the mass-forming type with invasion of Glisson's sheath.

Entities:  

Mesh:

Year:  1998        PMID: 9752860     DOI: 10.1046/j.1365-2168.1998.00815.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  23 in total

1.  Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma.

Authors:  Yuji Morine; Mitsuo Shimada; Tohru Utsunomiya; Satoru Imura; Tetsuya Ikemoto; Jun Hanaka; Mami Kanamoto; Nobuhiro Kurita; Hidenori Miyake
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

Review 2.  Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects.

Authors:  Lynn Jeanette Savic; Julius Chapiro; Jean-François H Geschwind
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

3.  CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions.

Authors:  I Gütgemann; S Haas; J P Berg; H Zhou; R Büttner; H-P Fischer
Journal:  Virchows Arch       Date:  2006-01-13       Impact factor: 4.064

4.  Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.

Authors:  Jieun Koh; Yong Eun Chung; Ji Hae Nahm; Ha Yan Kim; Kyung-Sik Kim; Young Nyun Park; Myeong-Jin Kim; Jin-Young Choi
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

5.  Intrahepatic cholangiocarcinoma.

Authors:  Kimberly M Brown; Abhishek D Parmar; David A Geller
Journal:  Surg Oncol Clin N Am       Date:  2014-04       Impact factor: 3.495

Review 6.  Surgical options for intrahepatic cholangiocarcinoma.

Authors:  Kui Wang; Han Zhang; Yong Xia; Jian Liu; Feng Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 7.  Epidemiology and surgical management of intrahepatic cholangiocarcinoma.

Authors:  Han Zhang; Feng Shen; Jun Han; Yi-Nan Shen; Guo-Qiang Xie; Meng-Chao Wu; Tian Yang
Journal:  Hepat Oncol       Date:  2015-11-30

8.  Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.

Authors:  Shiro Miwa; Shinichi Miyagawa; Akira Kobayashi; Yasuhiko Akahane; Takenari Nakata; Motohiro Mihara; Kei Kusama; Junpei Soeda; Shinichiro Ogawa
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

9.  Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas.

Authors:  Kejun Zhang; Bingyuan Zhang; Yun Lu; Chuandong Sun; Wei Zhao; Xuelong Jiao; Jilin Hu; Peng Mu; Hai Lu; Changyong Zhou
Journal:  Med Oncol       Date:  2010-12-01       Impact factor: 3.064

10.  Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.

Authors:  Jongha Park; Myung-Hwan Kim; Kyu-Pyo Kim; Do Hyun Park; Sung-Hoon Moon; Tae Jun Song; Junbum Eum; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.